How early placenta-forming cells (trophoblasts) develop
Pathways Affecting Trophoblast Development
This research looks at signals that tell early placenta cells how to change so pregnancy can be established, using lab models and patient-derived cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-11318978 on NIH RePORTER |
What this research studies
If you've had trouble getting pregnant or had placenta-related complications, this project looks at the molecular signals that tell early placenta cells (trophoblasts) when to stop being stem-like and start invading the uterus. Researchers will study two key signaling systems (activin–FSTL3 and WNT–NOTUM) using rat models and human trophoblast stem cells grown from patient tissue in the lab. They will use genetic and biochemical methods to turn these signals up or down and watch how the cells change. The goal is to learn why invasive trophoblasts sometimes fail to develop properly and how that contributes to failed or complicated pregnancies.
Who could benefit from this research
Good fit: Ideal candidates for any direct participation would include people with a history of implantation failure, recurrent pregnancy loss, or placenta-related complications who can donate early pregnancy or placental tissue under consent.
Not a fit: People without pregnancy-related concerns or those seeking immediate clinical treatment are unlikely to receive direct benefits because this is laboratory-based, preclinical research.
Why it matters
Potential benefit: If successful, this work could identify biological targets to help prevent pregnancy loss or improve treatments for people who cannot establish or maintain a healthy pregnancy.
How similar studies have performed: Related WNT and activin pathway work has implicated these signals in trophoblast behavior before, but using patient-specific human trophoblast stem cells to pinpoint mechanisms is a newer approach.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Soares, Michael J — University of Kansas Medical Center
- Study coordinator: Soares, Michael J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.